Helse ·
Heart Drug Setbacks and Health Tech
Kilder
- STAT: Why two promising heart drugs flopped and what’s next
- Finance: Ethan Weiss: Two Trial Flops End the "Genetics Is Undefeated" Era in Heart Drugs - finance.biggo.com
- Cardiacwire: Novo, Novartis, and How Two Trials Cast Doubt on CVD Biomarkers - Cardiac Wire
- Kff: Are Health Insurers to Blame for Our Health System Problems?
- Beckershospitalreview: American Heart Association cardiovascular risk tool integrated into Epic
- Newsroom: American Heart Association PREVENT equations now integrated into national electronic health record platform - www.heart.org
- Techtarget: ARPA-H selects 6 teams for agentic cardiovascular AI program - TechTarget
- STAT: STAT+: Five midterm races to watch that could be crucial for vaccine policy
- Raps: Recon: UK unveils recommendations for regulating AI in medicine; FDA halts new enrollment in Biohaven epilepsy trials - RAPS
- Thehill: Trump promises Obamacare rebates to people in swing states - The Hill
- STAT: STAT+: Cancer medicines remain in short supply across the U.S., survey finds
- STAT: The gifts from pharma companies that keep on giving - STAT
- STAT: Pharmalittle: We're reading about a Novartis investor seeking a shake-up, a Gilead setback, and more - STAT
- Beckershospitalreview: Apple Watch Series 12 debuts heart sensing, readiness score
- Apple: Introducing Apple Watch Series 12, with the all-new Health Sensing System - Apple
- Counterpointresearch: Apple Launches Watch Series 12 and Ultra 4: New Chip Powers Health and AI Features - counterpointresearch.com
- Apple: Apple advances health and fitness capabilities using Apple Intelligence - Apple
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.